,reactionmeddraversionpt,reactionmeddrapt,reactionoutcome,safetyreportid
0,22.0,Death,5,16177186
1,22.0,Product use in unapproved indication,6,16177186
0,22.0,Gastrointestinal infection,6,16177203
1,22.0,Neurotoxicity,6,16177203
2,22.0,Bone marrow failure,6,16177203
0,22.0,Dermatitis bullous,6,16177311
0,22.0,Squamous cell carcinoma,6,16177313
0,22.0,Neutropenia,6,16177346
1,22.0,Anaemia,6,16177346
2,22.0,Leukopenia,1,16177346
0,22.0,Seizure,1,16177359
1,22.0,Malignant neoplasm progression,5,16177359
0,22.1,Lymphadenopathy mediastinal,6,16177364
1,22.1,Atrial fibrillation,1,16177364
2,22.1,Pneumonia,5,16177364
0,22.0,Product use in unapproved indication,6,16177366
1,22.0,Death,5,16177366
0,22.0,Sudden death,5,16177367
1,22.0,Malignant neoplasm progression,5,16177367
0,22.0,Fatigue,3,16177377
1,22.0,Drug hypersensitivity,6,16177377
2,22.0,Affective disorder,6,16177377
3,22.0,Bladder disorder,6,16177377
4,22.0,Pollakiuria,3,16177377
5,22.0,Malaise,6,16177377
6,22.0,Substance-induced psychotic disorder,6,16177377
7,22.0,Balance disorder,3,16177377
0,22.0,Atrial fibrillation,3,16177389
1,22.0,Cardiac failure,3,16177389
0,22.0,Pyrexia,6,16177396
1,22.0,Chills,6,16177396
2,22.0,Polyneuropathy,2,16177396
3,22.0,Skin swelling,6,16177396
4,22.0,Skin hypertrophy,6,16177396
0,22.0,Fatigue,1,16177483
1,22.0,Pain,1,16177483
2,22.0,Asthenia,3,16177483
3,22.0,Prostatic specific antigen increased,6,16177483
4,22.0,Headache,6,16177483
5,22.0,Decreased appetite,6,16177483
6,22.0,Hot flush,6,16177483
7,22.0,Nausea,1,16177483
0,22.0,Flushing,1,16177526
1,22.0,Chest discomfort,1,16177526
0,22.1,Peripheral swelling,6,16177579
1,22.1,Diarrhoea,3,16177579
2,22.1,Abdominal distension,6,16177579
0,22.0,Throat irritation,1,16177642
1,22.0,Cough,1,16177642
2,22.0,Hypersensitivity,1,16177642
3,22.0,Pruritus generalised,1,16177642
4,22.0,Diarrhoea,1,16177642
0,22.0,Cholecystitis chronic,6,16177666
0,22.1,Hyperthyroidism,6,16177673
1,22.1,Neutropenia,3,16177673
0,22.0,Body temperature increased,1,16177674
1,22.0,Pyrexia,1,16177674
0,22.0,Liver function test abnormal,3,16177679
0,22.0,Neurotoxicity,6,16177682
0,22.0,Dehydration,2,16177683
1,22.0,Rhabdomyolysis,1,16177683
2,22.0,Pyrexia,2,16177683
0,22.0,Cardiac failure acute,2,16177688
1,22.0,Oedema peripheral,2,16177688
0,22.0,Hyperkalaemia,1,16177699
1,22.0,Coma,1,16177699
2,22.0,Shock,1,16177699
3,22.0,Lactic acidosis,1,16177699
4,22.0,Vomiting,1,16177699
5,22.0,Acute kidney injury,2,16177699
6,22.0,Diarrhoea,1,16177699
7,22.0,Dehydration,1,16177699
0,22.0,Malignant neoplasm progression,6,16177707
1,22.0,PTEN gene mutation,6,16177707
2,22.0,Metastases to bone,6,16177707
3,22.0,PIK3CA-activated mutation,6,16177707
0,22.0,Interstitial lung disease,5,16177738
1,22.0,Hepatic function abnormal,6,16177738
0,22.0,Haemorrhoids,1,16177764
1,22.0,Pyrexia,6,16177764
2,22.0,Neurotoxicity,3,16177764
3,22.0,Dyspepsia,1,16177764
4,22.0,Aphthous ulcer,1,16177764
5,22.0,Pain,1,16177764
6,22.0,Nausea,1,16177764
7,22.0,Rash pustular,3,16177764
8,22.0,Conjunctivitis,1,16177764
9,22.0,Asthenia,1,16177764
10,22.0,Diarrhoea,1,16177764
11,22.0,Rash,1,16177764
12,22.0,Pollakiuria,1,16177764
13,22.0,Constipation,1,16177764
14,22.0,Stomatitis,1,16177764
0,22.0,Radiation interaction,6,16177818
1,22.0,Portal hypertension,6,16177818
2,22.0,Hepatic failure,5,16177818
3,22.0,Duodenal ulcer haemorrhage,6,16177818
4,22.0,Neuropathy peripheral,6,16177818
0,22.0,General physical health deterioration,3,16177840
1,22.0,Tubulointerstitial nephritis,4,16177840
0,22.0,Headache,1,16177852
1,22.0,Hyperhidrosis,1,16177852
2,22.0,Atrial fibrillation,1,16177852
0,22.0,Asphyxia,1,16177921
1,22.0,Respiratory tract oedema,1,16177921
2,22.0,Hypersensitivity,1,16177921
3,22.0,Treatment noncompliance,6,16177921
4,22.0,Angioedema,6,16177921
0,22.0,Polyneuropathy,6,16178019
1,22.0,Neutropenia,6,16178019
0,22.0,Hepatic function abnormal,2,16178062
0,22.0,Seasonal allergy,6,16178086
1,22.0,Tinnitus,6,16178086
2,22.0,Deafness,6,16178086
0,22.0,Influenza,1,16178113
1,22.0,Pneumonia,1,16178113
0,22.0,Bronchospasm,1,16178187
1,22.0,Respiratory failure,1,16178187
0,22.0,Product dose omission,6,16178229
1,22.0,Product dispensing issue,6,16178229
2,22.0,No adverse event,6,16178229
0,22.0,Pain,1,16178234
1,22.0,Bile duct obstruction,2,16178234
0,22.0,Prostatic specific antigen increased,2,16178244
1,22.0,Cataract,2,16178244
2,22.0,Implantable defibrillator insertion,2,16178244
0,22.0,Asthenia,6,16178247
1,22.0,Malignant neoplasm progression,5,16178247
2,22.0,Pain,6,16178247
0,22.0,Blood magnesium decreased,1,16178305
1,22.0,Malaise,1,16178305
2,22.0,Body temperature decreased,1,16178305
0,22.0,Incorrect dose administered by product,6,16178320
1,22.0,No adverse event,6,16178320
2,22.0,Product preparation error,6,16178320
0,22.0,Hepatic encephalopathy,5,16178355
1,22.0,Portal hypertension,6,16178355
2,22.0,Nodular regenerative hyperplasia,6,16178355
3,22.0,Radiation interaction,6,16178355
0,22.0,Diarrhoea,6,16178404
0,22.0,Malignant neoplasm progression,6,16178411
0,22.0,Pelvic venous thrombosis,6,16178428
1,22.0,Gangrene,3,16178428
0,22.0,Polyneuropathy,6,16178432
0,22.0,Right ventricular failure,5,16178439
1,22.0,Depression,6,16178439
2,22.0,Somatic symptom disorder,6,16178439
3,22.0,Malignant neoplasm progression,6,16178439
4,22.0,Panic disorder,6,16178439
5,22.0,Pulmonary embolism,5,16178439
0,22.0,Oropharyngeal discomfort,1,16178462
1,22.0,Cough,1,16178462
2,22.0,Back pain,1,16178462
3,22.0,Chest pain,1,16178462
0,22.0,Bladder cancer recurrent,3,16178492
1,22.0,Product dose omission,6,16178492
0,22.0,Somnolence,1,16178498
1,22.0,Hot flush,1,16178498
2,22.0,Oxygen saturation decreased,1,16178498
3,22.0,Nausea,1,16178498
4,22.0,Dyspnoea,1,16178498
5,22.0,Dysphagia,1,16178498
0,22.0,Nausea,1,16178514
1,22.0,Blood pressure increased,6,16178514
2,22.0,Urinary tract infection,1,16178514
3,22.0,Vulvovaginal pruritus,6,16178514
4,22.0,Sensitive skin,6,16178514
5,22.0,Gastritis,1,16178514
6,22.0,Anxiety,1,16178514
7,22.0,Lip blister,6,16178514
8,22.0,Decreased appetite,6,16178514
9,22.0,Drug ineffective,6,16178514
10,22.0,Oral mucosal blistering,6,16178514
11,22.0,Dehydration,1,16178514
12,22.0,Vomiting,1,16178514
13,22.0,Abdominal pain,6,16178514
0,22.0,Erythema,,16178541
1,22.0,Cough,,16178541
2,22.0,Chest discomfort,,16178541
3,22.0,Dyspnoea,,16178541
0,22.0,Hypersensitivity,1,16178551
1,22.0,Rash erythematous,1,16178551
2,22.0,Pyrexia,1,16178551
3,22.0,Urticaria,1,16178551
4,22.0,Malaise,6,16178551
5,22.0,Product use in unapproved indication,6,16178551
6,22.0,Nausea,6,16178551
7,22.0,Perivascular dermatitis,1,16178551
8,22.0,Eczema,1,16178551
0,22.0,Rash,,16178563
0,22.0,Cystoid macular oedema,1,16178598
0,22.0,Lactic acidosis,2,16178604
1,22.0,Acute kidney injury,2,16178604
2,22.0,Rales,1,16178604
3,22.0,Diarrhoea,1,16178604
4,22.0,Oedema peripheral,1,16178604
5,22.0,Dyspnoea,2,16178604
0,22.0,Heart rate abnormal,6,16178619
1,22.0,Blood pressure decreased,6,16178619
2,22.0,Malaise,6,16178619
3,22.0,Treatment noncompliance,6,16178619
4,22.0,Drug hypersensitivity,1,16178619
5,22.0,Diarrhoea,6,16178619
0,22.0,Liver function test increased,,16178647
1,22.0,Plasmapheresis,,16178647
2,22.0,Cardiac arrest,,16178647
3,22.0,Myasthenia gravis,,16178647
4,22.0,Respiratory depression,,16178647
5,22.0,Procedural complication,,16178647
0,22.0,Death,5,16178735
1,22.0,Pneumonia,6,16178735
0,22.0,Oral cavity fistula,3,16178838
1,22.0,Off label use,6,16178838
2,22.0,Osteonecrosis of jaw,3,16178838
0,22.0,Cardiac dysfunction,3,16178889
0,22.1,Transaminases increased,1,16178902
1,22.1,Tumour cavitation,3,16178902
2,22.1,Tubulointerstitial nephritis,2,16178902
3,22.1,Haemoptysis,5,16178902
0,22.0,Toxic encephalopathy,2,16178930
0,22.1,Clostridium difficile colitis,4,16178966
1,22.1,Clostridium test positive,1,16178966
2,22.1,Pyrexia,1,16178966
0,22.0,Cellulitis,6,16178967
1,22.0,Lymphangitis,6,16178967
0,22.0,Haemoglobin abnormal,3,16178975
1,22.0,International normalised ratio abnormal,3,16178975
2,22.0,Anaemia,3,16178975
0,22.1,Fatigue,3,16179014
1,22.1,Burning sensation,1,16179014
2,22.1,Weight decreased,3,16179014
3,22.1,Nocturia,3,16179014
4,22.1,Pyrexia,6,16179014
5,22.1,Incorrect drug administration rate,3,16179014
6,22.1,Injection site mass,3,16179014
7,22.1,Product administered at inappropriate site,6,16179014
8,22.1,Oedema,3,16179014
9,22.1,Dyspnoea exertional,3,16179014
10,22.1,Injection site swelling,2,16179014
11,22.1,Dysstasia,3,16179014
12,22.1,Constipation,3,16179014
13,22.1,Vertigo,3,16179014
14,22.1,Injection site nodule,2,16179014
15,22.1,Coronary artery occlusion,3,16179014
16,22.1,Weight increased,3,16179014
17,22.1,Injection site pain,3,16179014
18,22.1,Myalgia,1,16179014
19,22.1,Gastric ulcer haemorrhage,3,16179014
20,22.1,Hot flush,3,16179014
21,22.1,Myocardial infarction,3,16179014
22,22.1,Injection site pain,3,16179014
0,22.0,Perforation,6,16179044
0,22.0,Death,5,16179057
1,22.0,Asthenia,6,16179057
0,22.0,EGFR gene mutation,6,16179058
0,22.0,Colitis,3,16179093
0,22.0,Leukopenia,1,16179108
0,22.0,Fatigue,3,16179128
1,22.0,Myalgia,6,16179128
2,22.0,Musculoskeletal stiffness,6,16179128
3,22.0,Taste disorder,6,16179128
4,22.0,Mucosal inflammation,3,16179128
0,22.0,Abdominal hernia,2,16179149
0,22.1,Malaise,3,16179275
1,22.1,Haemoptysis,6,16179275
2,22.1,Neoplasm progression,6,16179275
0,22.0,Product dose omission,6,16179286
1,22.0,No adverse event,6,16179286
2,22.0,Product availability issue,6,16179286
0,22.0,Nausea,6,16179309
1,22.0,Arthralgia,6,16179309
2,22.0,Insomnia,6,16179309
3,22.0,Fatigue,6,16179309
4,22.0,Viral infection,6,16179309
5,22.0,Cardiac failure congestive,6,16179309
6,22.0,Asthenia,6,16179309
0,22.1,Thrombosis,6,16179376
1,22.1,Neoplasm progression,6,16179376
2,22.1,Death,5,16179376
0,22.0,Death,5,16179385
0,22.0,Acute kidney injury,3,16179457
0,22.0,Febrile neutropenia,2,16179458
1,22.0,Pancytopenia,2,16179458
0,22.0,Laryngeal oedema,1,16179460
1,22.0,Erythema,1,16179460
0,22.0,Diarrhoea,3,16179509
1,22.0,Decreased appetite,3,16179509
2,22.0,Pain,3,16179509
3,22.0,Insomnia,3,16179509
4,22.0,Weight decreased,3,16179509
5,22.0,Fatigue,3,16179509
6,22.0,Nausea,3,16179509
7,22.0,Nephrolithiasis,3,16179509
0,22.1,Neoplasm progression,6,16179530
1,22.1,Gait inability,6,16179530
2,22.1,Neuropathy peripheral,6,16179530
3,22.1,Vertigo positional,6,16179530
4,22.1,Varicose vein,6,16179530
5,22.1,Alopecia,6,16179530
6,22.1,Diarrhoea,6,16179530
7,22.1,Weight decreased,6,16179530
8,22.1,Glaucoma,6,16179530
9,22.1,Hypercholesterolaemia,6,16179530
10,22.1,Abdominal pain upper,6,16179530
11,22.1,Decreased appetite,6,16179530
12,22.1,Nausea,6,16179530
0,22.0,Hypertension,1,16179581
0,22.0,Hot flush,3,16179599
1,22.0,Injection site mass,3,16179599
0,22.0,Injection site mass,3,16179601
0,22.0,Vomiting,3,16179604
0,22.0,Urticaria,3,16179608
0,22.0,Injection site induration,1,16179610
1,22.0,Injection site erythema,1,16179610
0,22.0,Dyspnoea,1,16179614
0,22.0,Injection site mass,6,16179615
0,22.0,Product dose omission,6,16179618
0,22.0,Discomfort,1,16179624
1,22.0,Fatigue,6,16179624
0,22.0,Injection site induration,3,16179627
1,22.0,Injection site erythema,3,16179627
0,22.0,Myalgia,1,16179633
1,22.0,Insomnia,3,16179633
2,22.0,Arthralgia,1,16179633
3,22.0,Hot flush,3,16179633
4,22.0,Inappropriate schedule of product administration,6,16179633
5,22.0,Injection site pain,3,16179633
6,22.0,Off label use,6,16179633
7,22.0,Injection site erythema,3,16179633
0,22.0,Injection site swelling,3,16179636
1,22.0,Injection site infection,3,16179636
2,22.0,Erythema,3,16179636
3,22.0,Injection site erythema,3,16179636
4,22.0,Injection site pain,3,16179636
0,22.0,Injection site erythema,3,16179638
1,22.0,Injection site mass,3,16179638
0,22.0,Off label use,6,16179640
1,22.0,Antiandrogen therapy,3,16179640
2,22.0,Weight increased,6,16179640
0,22.0,Anaphylactic reaction,6,16179642
1,22.0,Back pain,3,16179642
0,22.0,Blood testosterone abnormal,6,16179644
1,22.0,Product lot number issue,6,16179644
2,22.0,Prostatic specific antigen abnormal,6,16179644
0,22.0,Injection site mass,3,16179646
1,22.0,Injection site induration,3,16179646
2,22.0,Injection site erythema,3,16179646
0,22.0,Death,5,16179647
0,22.0,Blood testosterone abnormal,3,16179649
1,22.0,Prostatic specific antigen abnormal,3,16179649
2,22.0,Product lot number issue,3,16179649
0,22.0,Blood testosterone abnormal,6,16179652
1,22.0,Prostatic specific antigen abnormal,6,16179652
2,22.0,Product lot number issue,6,16179652
0,22.0,Prostate cancer,6,16179654
1,22.0,Drug ineffective,6,16179654
0,22.0,Injection site reaction,3,16179655
0,22.0,Hot flush,3,16179656
1,22.0,Arthralgia,3,16179656
2,22.0,Headache,3,16179656
3,22.0,Chills,3,16179656
0,22.0,Hot flush,3,16179660
0,22.0,Infection,1,16179661
0,22.0,Injection site erythema,3,16179663
0,22.0,Cellulitis,3,16179664
0,22.0,Incorrect dose administered,6,16179665
0,22.0,Injection site erythema,3,16179667
1,22.0,Injection site swelling,3,16179667
2,22.0,Injection site cellulitis,3,16179667
0,22.0,Injection site pain,2,16179668
0,22.0,Injection site erythema,6,16179669
1,22.0,Hot flush,1,16179669
2,22.0,Wrong technique in product usage process,6,16179669
3,22.0,Injection site induration,6,16179669
0,22.0,Blood testosterone increased,6,16179670
1,22.0,Prostatic specific antigen increased,6,16179670
0,22.0,Injection site erythema,3,16179671
1,22.0,Injection site swelling,3,16179671
0,22.0,Blood testosterone increased,6,16179680
1,22.0,Prostatic specific antigen increased,6,16179680
0,22.0,Injection site urticaria,6,16179681
0,22.0,Urinary hesitation,3,16179690
1,22.0,Injection site pain,1,16179690
2,22.0,Blood glucose fluctuation,3,16179690
3,22.0,Nocturia,3,16179690
0,22.0,Somnolence,6,16179693
0,22.0,Feeling hot,6,16179694
1,22.0,Presyncope,6,16179694
2,22.0,Cold sweat,6,16179694
0,22.0,Loss of libido,3,16179699
0,22.0,Injection site pain,2,16179700
1,22.0,Injection site mass,3,16179700
0,22.0,Musculoskeletal pain,3,16179705
1,22.0,Back pain,3,16179705
0,22.0,Injection site swelling,3,16179716
1,22.0,Injection site induration,3,16179716
0,22.0,Anxiety,6,16179728
0,22.0,Actinic keratosis,6,16179731
1,22.0,Neoplasm progression,6,16179731
2,22.0,Bronchiolitis,1,16179731
0,22.0,Death,5,16179757
0,22.0,Death,5,16179783
1,22.0,Off label use,6,16179783
2,22.0,Intentional product use issue,6,16179783
0,22.1,Blood pressure increased,6,16179816
1,22.1,Neoplasm progression,6,16179816
0,22.1,Cataract,1,16179838
1,22.1,Product use issue,6,16179838
2,22.1,Off label use,6,16179838
0,22.0,Disease progression,,16179847
0,22.0,Tachyarrhythmia,1,16179851
0,22.0,Nausea,,16179852
1,22.0,Blood glucose abnormal,,16179852
0,22.0,Acute kidney injury,2,16179855
0,22.0,Cataract,6,16179862
0,22.0,Myocardial infarction,,16179863
0,22.0,Presyncope,,16179874
1,22.0,Full blood count decreased,,16179874
2,22.0,Asthenia,,16179874
0,22.0,Feeling cold,,16179877
1,22.0,Dyspnoea,,16179877
0,22.0,Hypocalcaemia,2,16179879
0,22.0,Malignant neoplasm progression,5,16179899
0,22.0,Erythema,,16179923
1,22.0,Cough,,16179923
2,22.0,Infusion related reaction,,16179923
3,22.0,Wheezing,,16179923
0,22.0,Drug interaction,1,16179947
1,22.0,Malaise,1,16179947
2,22.0,Diarrhoea,1,16179947
0,22.0,Radiation hepatitis,1,16179955
1,22.0,Radiation pneumonitis,1,16179955
0,22.0,Stomatitis,3,16179978
1,22.0,Taste disorder,3,16179978
2,22.0,Diarrhoea,3,16179978
3,22.0,Decreased appetite,3,16179978
4,22.0,Malaise,3,16179978
5,22.0,Dizziness,6,16179978
0,22.0,Neutropenia,1,16179987
0,22.0,Drug ineffective for unapproved indication,6,16179994
0,22.0,Polycythaemia,3,16180007
1,22.0,Mucosal inflammation,6,16180007
0,22.0,Chronic obstructive pulmonary disease,,16180028
0,22.0,Myocardial infarction,,16180037
0,22.0,Hospitalisation,,16180051
0,22.0,Fatigue,,16180065
0,22.0,Thrombocytopenia,,16180085
0,22.0,Cardiac failure congestive,6,16180137
1,22.0,Angiopathy,6,16180137
2,22.0,Skin ulcer,3,16180137
0,22.0,Prostate cancer metastatic,5,16180207
0,22.0,Pyrexia,3,16180304
1,22.0,Vomiting,3,16180304
2,22.0,Abdominal pain upper,3,16180304
3,22.0,Infection,3,16180304
0,22.0,Malignant neoplasm progression,3,16180312
0,22.0,Bone pain,6,16180547
1,22.0,Chest discomfort,6,16180547
2,22.0,Breast pain,6,16180547
3,22.0,Chest pain,6,16180547
4,22.0,Breast discomfort,6,16180547
5,22.0,Discomfort,6,16180547
0,22.0,Eating disorder,1,16180548
1,22.0,Renal cancer,6,16180548
2,22.0,Decreased appetite,6,16180548
3,22.0,Diarrhoea,1,16180548
0,22.0,Pulmonary embolism,6,16180557
0,22.0,Gingival disorder,3,16180575
0,22.1,Drug ineffective,6,16180584
0,22.1,Dyspnoea,6,16180586
0,22.0,Alopecia,3,16180588
1,22.0,Hair texture abnormal,3,16180588
2,22.0,Hair disorder,3,16180588
3,22.0,Alopecia,3,16180588
4,22.0,Hair texture abnormal,3,16180588
5,22.0,Madarosis,3,16180588
6,22.0,Hair colour changes,3,16180588
0,22.0,Oedema,3,16180622
1,22.0,Muscular weakness,3,16180622
2,22.0,Neuralgia,3,16180622
3,22.0,Anaemia,3,16180622
0,22.0,Platelet count decreased,6,16180639
0,22.0,Malignant neoplasm progression,6,16180646
1,22.0,Non-small cell lung cancer metastatic,6,16180646
0,22.0,Aphonia,3,16180647
0,22.0,Lung disorder,3,16180682
0,22.0,Dizziness,1,16180724
1,22.0,Alopecia,3,16180724
2,22.0,Peripheral swelling,3,16180724
3,22.0,Fatigue,3,16180724
0,22.0,Cystitis,3,16180779
1,22.0,Urinary tract infection,1,16180779
0,22.0,Alopecia,3,16180791
1,22.0,Madarosis,3,16180791
2,22.0,Hair colour changes,3,16180791
3,22.0,Hair texture abnormal,3,16180791
4,22.0,Hair disorder,3,16180791
0,22.0,Hair texture abnormal,6,16180793
1,22.0,Hair disorder,6,16180793
2,22.0,Hair colour changes,6,16180793
3,22.0,Madarosis,3,16180793
4,22.0,Alopecia,3,16180793
0,22.0,Death,5,16180797
0,22.1,Death,5,16180800
1,22.1,Renal failure,6,16180800
2,22.1,Bronchitis,1,16180800
0,22.0,Rash pruritic,3,16180804
1,22.0,Diarrhoea,1,16180804
0,22.0,Hepatic cyst,6,16180813
1,22.0,Intra-abdominal fluid collection,6,16180813
0,22.0,Diarrhoea,6,16180822
0,22.0,Hair texture abnormal,3,16180845
1,22.0,Alopecia,3,16180845
2,22.0,Madarosis,3,16180845
3,22.0,Hair colour changes,3,16180845
4,22.0,Hair disorder,3,16180845
0,22.0,Neoplasm progression,6,16180856
0,22.0,Alopecia,6,16180857
1,22.0,Hair texture abnormal,6,16180857
2,22.0,Hair disorder,6,16180857
3,22.0,Madarosis,6,16180857
4,22.0,Hair colour changes,6,16180857
0,22.1,Alopecia,3,16180859
1,22.1,Madarosis,3,16180859
0,22.0,Death,5,16180906
1,22.0,Hip fracture,2,16180906
2,22.0,Orthostatic hypotension,1,16180906
3,22.0,Abdominal discomfort,1,16180906
4,22.0,Pain in extremity,3,16180906
5,22.0,Dehydration,6,16180906
6,22.0,Constipation,1,16180906
7,22.0,Decreased appetite,3,16180906
8,22.0,Malignant neoplasm progression,6,16180906
0,22.0,Death,5,16180907
0,22.0,Death,5,16180908
0,22.0,Eating disorder,6,16180909
1,22.0,Asthenia,6,16180909
2,22.0,Diarrhoea,6,16180909
3,22.0,Sinus headache,6,16180909
4,22.0,Unresponsive to stimuli,6,16180909
5,22.0,Hallucination,6,16180909
6,22.0,Weight decreased,6,16180909
7,22.0,Insomnia,6,16180909
0,22.0,Unevaluable event,6,16180911
1,22.0,Pancreatitis,6,16180911
0,22.0,Death,5,16180912
0,22.0,Malignant neoplasm progression,5,16180913
0,22.0,Nephrocalcinosis,3,16180967
1,22.0,Maternal exposure during pregnancy,6,16180967
0,22.0,White blood cell count decreased,6,16180975
1,22.0,Full blood count decreased,6,16180975
0,22.0,Injection site haemorrhage,1,16181015
1,22.0,Injection site nodule,1,16181015
2,22.0,Wrong technique in product usage process,1,16181015
3,22.0,Injection site swelling,1,16181015
4,22.0,Fatigue,1,16181015
5,22.0,Fatigue,1,16181015
0,22.0,Anaphylactoid reaction,1,16181028
0,22.0,Death,5,16181051
0,22.0,Lung neoplasm malignant,5,16181111
1,22.0,Prescribed overdose,6,16181111
0,22.0,Neutropenia,2,16181123
0,22.0,Gastrointestinal perforation,2,16181157
0,22.0,Death,5,16181171
0,22.1,Visual impairment,3,16181198
1,22.1,Optic neuritis,3,16181198
2,22.1,Visual field defect,3,16181198
3,22.1,Amaurosis,3,16181198
0,22.0,Death,5,16181200
0,22.0,Death,5,16181202
0,22.0,Tremor,1,16181203
1,22.0,Body temperature increased,1,16181203
0,22.0,Staphylococcus test positive,6,16181204
1,22.0,Off label use,6,16181204
2,22.0,Subendocardial ischaemia,5,16181204
3,22.0,Arteriosclerosis,5,16181204
4,22.0,Idiopathic pulmonary fibrosis,5,16181204
5,22.0,Pyrexia,3,16181204
6,22.0,Brain oedema,5,16181204
7,22.0,Malignant neoplasm progression,5,16181204
8,22.0,Cerebral artery thrombosis,5,16181204
9,22.0,Interstitial lung disease,3,16181204
0,22.0,Stomatitis,1,16181211
1,22.0,Bacterial translocation,6,16181211
0,22.0,Erythema,1,16181237
1,22.0,Hypotension,1,16181237
2,22.0,Oxygen saturation decreased,1,16181237
3,22.0,Flushing,1,16181237
4,22.0,Nausea,1,16181237
5,22.0,Dyspnoea,1,16181237
0,22.0,Product lot number issue,3,16181241
1,22.0,Prostatic specific antigen abnormal,3,16181241
2,22.0,Blood testosterone abnormal,3,16181241
0,22.0,Malignant neoplasm progression,6,16181262
1,22.0,Urinary tract infection,6,16181262
2,22.0,Haemoglobin decreased,3,16181262
3,22.0,White blood cell count decreased,1,16181262
4,22.0,Headache,3,16181262
5,22.0,Tumour marker increased,6,16181262
6,22.0,Nausea,2,16181262
7,22.0,Taste disorder,3,16181262
8,22.0,Constipation,3,16181262
9,22.0,Off label use,6,16181262
10,22.0,Blood count abnormal,6,16181262
11,22.0,Drug ineffective,6,16181262
12,22.0,Fatigue,3,16181262
0,22.0,Death,5,16181339
1,22.0,Cerebral haemorrhage,5,16181339
0,22.0,Vena cava embolism,6,16181370
0,22.0,Colitis,6,16181431
0,22.0,Bone marrow failure,6,16181434
1,22.0,Gastrointestinal disorder,6,16181434
0,22.1,Altered state of consciousness,6,16181463
1,22.1,Insomnia,6,16181463
2,22.1,Staphylococcal infection,1,16181463
3,22.1,Atrial fibrillation,1,16181463
4,22.1,Cardiac failure,1,16181463
5,22.1,Sepsis,1,16181463
6,22.1,Delirium,6,16181463
7,22.1,Interstitial lung disease,5,16181463
8,22.1,Infection,6,16181463
9,22.1,Carbon dioxide increased,6,16181463
0,22.0,Abdominal pain,1,16181509
1,22.0,Appendicitis perforated,6,16181509
2,22.0,Enteritis,6,16181509
0,22.1,Stevens-Johnson syndrome,1,16181588
1,22.1,Breast cancer,5,16181588
2,22.1,Drug-induced liver injury,6,16181588
0,22.0,Palpitations,3,16181646
0,22.0,Depressed level of consciousness,6,16181720
1,22.0,Oedema peripheral,6,16181720
2,22.0,Delirium,6,16181720
3,22.0,Dysphoria,6,16181720
4,22.0,Vomiting,6,16181720
5,22.0,Dizziness,6,16181720
6,22.0,Anuria,1,16181720
7,22.0,Nausea,6,16181720
8,22.0,Speech disorder,6,16181720
9,22.0,Headache,6,16181720
10,22.0,Hyponatraemia,1,16181720
11,22.0,Mania,6,16181720
0,22.0,Depressed level of consciousness,1,16181722
1,22.0,Mania,1,16181722
2,22.0,Oedema peripheral,1,16181722
3,22.0,Nausea,1,16181722
4,22.0,Headache,1,16181722
5,22.0,Anuria,1,16181722
6,22.0,Vomiting,1,16181722
7,22.0,Hypoaesthesia,1,16181722
8,22.0,Delirium,1,16181722
9,22.0,Dysphoria,1,16181722
10,22.0,Speech disorder,1,16181722
11,22.0,Dizziness,1,16181722
12,22.0,Nausea,1,16181722
0,22.0,Pulmonary embolism,6,16181779
1,22.0,Pulmonary fibrosis,6,16181779
2,22.0,Thrombosis,6,16181779
3,22.0,Pneumonitis,6,16181779
0,22.0,Skin discolouration,2,16181802
1,22.0,Paralysis,2,16181802
2,22.0,Diarrhoea,1,16181802
0,22.1,Pulmonary fibrosis,6,16181879
1,22.1,Malignant neoplasm progression,6,16181879
2,22.1,Malignant neoplasm progression,6,16181879
3,22.1,Lymphadenopathy,6,16181879
4,22.1,Inappropriate schedule of product administration,6,16181879
5,22.1,Brachiocephalic vein thrombosis,6,16181879
6,22.1,Lumbar vertebral fracture,6,16181879
7,22.1,Oncologic complication,6,16181879
8,22.1,Colitis,6,16181879
0,22.1,Lymphangiosis carcinomatosa,6,16181883
1,22.1,Malignant neoplasm progression,6,16181883
2,22.1,Radiation pneumonitis,2,16181883
3,22.1,Bronchostenosis,6,16181883
4,22.1,Renal impairment,6,16181883
5,22.1,Vascular device infection,1,16181883
6,22.1,Thrombocytopenia,2,16181883
7,22.1,Squamous cell carcinoma of lung,5,16181883
8,22.1,Neutrophil count decreased,6,16181883
9,22.1,Pneumonia aspiration,6,16181883
10,22.1,Interstitial lung disease,2,16181883
11,22.1,Febrile neutropenia,1,16181883
12,22.1,White blood cell count decreased,6,16181883
13,22.1,Dehydration,6,16181883
14,22.1,Pneumonia,6,16181883
0,22.1,Diarrhoea,6,16182050
1,22.1,Nausea,1,16182050
2,22.1,Fatigue,6,16182050
3,22.1,Weight decreased,3,16182050
4,22.1,Anaemia,2,16182050
5,22.1,Decreased appetite,6,16182050
0,22.0,Flushing,6,16182070
1,22.0,Hyperpyrexia,1,16182070
0,22.0,Acute kidney injury,3,16182098
1,22.0,Dehydration,6,16182098
2,22.0,Nutritional condition abnormal,6,16182098
3,22.0,Condition aggravated,6,16182098
4,22.0,Decreased appetite,6,16182098
0,22.0,Hyperglycaemia,4,16182114
1,22.0,Diabetes mellitus,4,16182114
2,22.0,Thyroid disorder,4,16182114
0,22.0,Blood pressure decreased,6,16182118
1,22.0,Malaise,6,16182118
2,22.0,Pyrexia,6,16182118
3,22.0,Febrile neutropenia,3,16182118
4,22.0,Heart rate increased,6,16182118
5,22.0,Cytopenia,6,16182118
6,22.0,Headache,6,16182118
7,22.0,Abdominal pain,6,16182118
8,22.0,Chills,6,16182118
9,22.0,Cough,6,16182118
10,22.0,Diarrhoea,6,16182118
11,22.0,Pain in extremity,6,16182118
0,22.0,Product dose omission,6,16182202
1,22.0,Product availability issue,6,16182202
2,22.0,No adverse event,6,16182202
0,22.0,Bronchospasm,1,16182211
1,22.0,Respiratory failure,1,16182211
0,22.0,Ovarian cancer,3,16182325
0,22.0,Dyspnoea,1,16182342
1,22.0,Nausea,1,16182342
2,22.0,Oxygen saturation decreased,1,16182342
3,22.0,Dysphagia,1,16182342
4,22.0,Hot flush,1,16182342
5,22.0,Somnolence,1,16182342
0,22.0,Leukoplakia oral,6,16182419
1,22.0,Cough,6,16182419
0,22.0,Ocular hyperaemia,1,16182426
1,22.0,Photophobia,1,16182426
2,22.0,Hyperthermia,6,16182426
3,22.0,Anterior chamber flare,1,16182426
4,22.0,Myalgia,6,16182426
5,22.0,Arthralgia,6,16182426
6,22.0,Uveitis,1,16182426
7,22.0,Conjunctival hyperaemia,1,16182426
8,22.0,Dyspnoea,6,16182426
9,22.0,Gait disturbance,6,16182426
10,22.0,Hypokinesia,6,16182426
11,22.0,Eye pain,1,16182426
12,22.0,Fatigue,6,16182426
0,22.0,Neutropenia,1,16182427
1,22.0,White blood cell count decreased,6,16182427
0,22.0,Haemolytic anaemia,3,16182449
0,22.0,Hepatitis C,6,16182528
1,22.0,Hepatic failure,5,16182528
0,22.0,Toxic epidermal necrolysis,5,16182555
0,22.1,Antinuclear antibody increased,6,16182568
1,22.1,Arthritis,1,16182568
2,22.1,Radiation pneumonitis,2,16182568
0,22.0,Blood phosphorus decreased,1,16182574
1,22.0,Asthenia,1,16182574
2,22.0,Transaminases increased,1,16182574
3,22.0,Blood magnesium decreased,1,16182574
4,22.0,Neutropenia,1,16182574
5,22.0,Prothrombin time prolonged,1,16182574
6,22.0,Diarrhoea,6,16182574
7,22.0,Hypoalbuminaemia,1,16182574
8,22.0,Thrombocytopenia,6,16182574
9,22.0,Blood potassium decreased,1,16182574
0,22.0,Malignant neoplasm progression,6,16182584
1,22.0,Rectosigmoid cancer recurrent,6,16182584
2,22.0,Rectosigmoid cancer metastatic,6,16182584
3,22.0,Transient ischaemic attack,6,16182584
0,22.0,Death,5,16182598
1,22.0,Malignant neoplasm progression,6,16182598
0,22.0,Syncope,1,16182674
1,22.0,Colitis,1,16182674
0,22.0,Emotional distress,6,16182677
1,22.0,Impaired quality of life,6,16182677
2,22.0,Alopecia universalis,2,16182677
3,22.0,Psychological trauma,6,16182677
4,22.0,Pain,6,16182677
5,22.0,Anxiety,6,16182677
0,22.0,Respiratory tract infection,1,16182689
0,22.0,Fatigue,6,16182694
1,22.0,Cerebellar ataxia,2,16182694
2,22.0,Neurotoxicity,1,16182694
3,22.0,Nausea,6,16182694
0,22.0,Blood albumin decreased,3,16182697
1,22.0,Malignant neoplasm progression,5,16182697
2,22.0,Liver disorder,3,16182697
3,22.0,Platelet count decreased,3,16182697
4,22.0,Hepatic atrophy,6,16182697
0,22.0,Prostate cancer,5,16182736
1,22.0,Bone marrow disorder,5,16182736
2,22.0,Off label use,6,16182736
3,22.0,Refractory cytopenia with unilineage dysplasia,5,16182736
0,22.0,Treatment failure,6,16182863
1,22.0,Prostate cancer,6,16182863
0,22.1,Fall,6,16182888
1,22.1,Coccydynia,2,16182888
2,22.1,Disseminated intravascular coagulation,3,16182888
3,22.1,Pubis fracture,3,16182888
4,22.1,Fractured ischium,3,16182888
5,22.1,Bone marrow oedema,2,16182888
6,22.1,Interstitial lung disease,5,16182888
7,22.1,Pneumocystis jirovecii pneumonia,6,16182888
0,22.0,Death,5,16182899
0,22.0,Death,5,16182906
0,22.0,Bladder cancer recurrent,3,16182916
0,22.1,Radiation pneumonitis,1,16182938
1,22.1,Thirst,3,16182938
2,22.1,Dry mouth,6,16182938
3,22.1,Rheumatic disorder,2,16182938
4,22.1,Sputum purulent,3,16182938
0,22.0,Dermatitis,2,16182951
0,22.0,Wrong technique in product usage process,6,16182974
1,22.0,Therapeutic product effect decreased,6,16182974
0,22.0,Jaundice,6,16182982
1,22.0,Organ failure,6,16182982
2,22.0,Vomiting,2,16182982
3,22.0,Abdominal pain,6,16182982
4,22.0,Hepatic function abnormal,6,16182982
0,22.0,Electrocardiogram abnormal,1,16183019
1,22.0,Acute myocardial infarction,1,16183019
0,22.0,Malignant neoplasm progression,6,16183058
0,22.0,Constipation,6,16183061
0,22.0,Blood glucose decreased,6,16183077
0,22.0,Hospitalisation,6,16183093
0,22.0,Metastases to skin,6,16183104
1,22.0,Metastases to liver,6,16183104
2,22.0,Metastases to peritoneum,6,16183104
3,22.0,Malignant neoplasm progression,6,16183104
4,22.0,Metastases to bone,6,16183104
5,22.0,Breast cancer metastatic,6,16183104
0,22.0,Bone marrow failure,6,16183119
1,22.0,Proteinuria,6,16183119
2,22.0,Gastrointestinal disorder,6,16183119
3,22.0,Hypertension,6,16183119
4,22.0,Neurotoxicity,6,16183119
5,22.0,Diarrhoea,6,16183119
0,22.0,Emphysema,6,16183122
1,22.0,Cholecystitis,6,16183122
2,22.0,Renal cyst,6,16183122
3,22.0,Hepatic steatosis,6,16183122
4,22.0,Prostatic calcification,6,16183122
5,22.0,Hypersensitivity,6,16183122
0,22.0,Pyelonephritis acute,1,16183124
1,22.0,Malignant neoplasm progression,3,16183124
0,22.0,Arthritis,3,16183131
0,22.0,Febrile neutropenia,1,16183195
0,22.1,Intentional product use issue,6,16183203
1,22.1,Anaemia,6,16183203
2,22.1,Off label use,6,16183203
3,22.1,Toxic neuropathy,6,16183203
0,22.0,Hepatitis cholestatic,1,16183238
0,22.0,Anaphylactoid reaction,1,16183242
0,22.0,White blood cell count decreased,6,16183260
1,22.0,Cholecystitis chronic,6,16183260
2,22.0,Asthenia,6,16183260
3,22.0,Gastric leiomyoma,6,16183260
0,22.0,Dyspnoea,6,16183285
1,22.0,Death,5,16183285
0,22.1,Abdominal pain upper,6,16183288
1,22.1,Anal incontinence,6,16183288
2,22.1,Musculoskeletal pain,6,16183288
3,22.1,Cough,6,16183288
4,22.1,Blood pressure increased,6,16183288
5,22.1,Bone pain,6,16183288
6,22.1,Acne,6,16183288
7,22.1,Diarrhoea,6,16183288
8,22.1,Pain,6,16183288
9,22.1,Insomnia,6,16183288
10,22.1,Vomiting,6,16183288
11,22.1,Lymphadenopathy,6,16183288
0,22.0,Metastases to bone,6,16183299
1,22.0,Disease progression,6,16183299
2,22.0,Drug intolerance,6,16183299
3,22.0,Spinal pain,6,16183299
0,22.0,Generalised erythema,1,16183338
1,22.0,Hypotension,1,16183338
2,22.0,Oxygen saturation decreased,1,16183338
3,22.0,Pruritus generalised,1,16183338
4,22.0,Vision blurred,1,16183338
5,22.0,Nausea,1,16183338
6,22.0,Ocular hyperaemia,1,16183338
0,22.0,Rectal cancer recurrent,6,16183339
1,22.0,Malignant neoplasm progression,5,16183339
2,22.0,Rectal cancer stage II,5,16183339
0,22.0,Malaise,6,16183375
1,22.0,Dizziness,6,16183375
2,22.0,Peripheral swelling,6,16183375
3,22.0,Swelling face,6,16183375
4,22.0,Cardiac failure,6,16183375
0,22.0,Brain oedema,5,16183387
1,22.0,Cerebral artery thrombosis,5,16183387
2,22.0,Staphylococcus test positive,6,16183387
3,22.0,Interstitial lung disease,3,16183387
4,22.0,Arteriosclerosis,5,16183387
5,22.0,Idiopathic pulmonary fibrosis,5,16183387
6,22.0,Interstitial lung disease,6,16183387
7,22.0,Pyrexia,3,16183387
8,22.0,Malignant neoplasm progression,5,16183387
9,22.0,Subendocardial ischaemia,5,16183387
10,22.0,Condition aggravated,3,16183387
0,22.0,Hypokinesia,6,16183422
1,22.0,Urinary tract infection,6,16183422
2,22.0,Myelitis,6,16183422
3,22.0,Thrombosis,6,16183422
0,22.0,Electrocardiogram QT prolonged,6,16183424
1,22.0,Drug intolerance,6,16183424
2,22.0,Mobility decreased,2,16183424
0,22.0,Extremity necrosis,2,16183463
1,22.0,Skin ulcer,2,16183463
0,22.0,Ovarian cancer recurrent,6,16183465
0,22.0,Diarrhoea,6,16183475
0,22.0,Malignant neoplasm progression,3,16183503
0,22.0,Application site dryness,1,16183565
1,22.0,Product use in unapproved indication,6,16183565
0,22.0,Pyrexia,6,16183581
1,22.0,Cardiac disorder,6,16183581
2,22.0,Heart rate decreased,6,16183581
3,22.0,Atrial fibrillation,6,16183581
4,22.0,Asthenia,6,16183581
5,22.0,Acute myocardial infarction,6,16183581
6,22.0,Fatigue,6,16183581
7,22.0,Malaise,6,16183581
8,22.0,Fall,6,16183581
0,22.0,Aspiration,5,16183604
1,22.0,Vomiting,5,16183604
2,22.0,Orthopnoea,6,16183604
3,22.0,Respiratory failure,5,16183604
4,22.0,Dyspnoea,6,16183604
5,22.0,Breast cancer metastatic,5,16183604
6,22.0,Malignant pleural effusion,1,16183604
0,22.0,Osteomyelitis,6,16183652
1,22.0,Exposed bone in jaw,6,16183652
0,22.1,Fatigue,6,16183665
1,22.1,Headache,6,16183665
2,22.1,Intentional product use issue,6,16183665
3,22.1,Febrile neutropenia,6,16183665
4,22.1,Pulmonary fibrosis,6,16183665
5,22.1,Off label use,6,16183665
6,22.1,Asthenia,6,16183665
7,22.1,Weight decreased,6,16183665
0,22.0,Arthralgia,1,16183668
1,22.0,Malignant neoplasm progression,6,16183668
0,22.0,Type 2 diabetes mellitus,4,16183696
0,22.0,Rash,6,16183705
1,22.0,Malignant neoplasm progression,6,16183705
2,22.0,Drug resistance,6,16183705
3,22.0,Drug ineffective,6,16183705
0,22.1,Nasal congestion,6,16183717
1,22.1,Sunburn,6,16183717
2,22.1,Skin discolouration,6,16183717
3,22.1,Feeling abnormal,6,16183717
4,22.1,Headache,1,16183717
5,22.1,Haemorrhagic diathesis,6,16183717
6,22.1,Pancytopenia,3,16183717
7,22.1,Sinusitis,1,16183717
8,22.1,Memory impairment,6,16183717
9,22.1,Fatigue,3,16183717
10,22.1,Product dose omission,6,16183717
11,22.1,Blood pressure fluctuation,1,16183717
12,22.1,Contusion,1,16183717
13,22.1,Nausea,6,16183717
14,22.1,Dizziness,1,16183717
15,22.1,Constipation,3,16183717
16,22.1,Hyperhidrosis,6,16183717
17,22.1,Abdominal pain upper,1,16183717
18,22.1,Drug hypersensitivity,6,16183717
19,22.1,Skin atrophy,3,16183717
20,22.1,Red blood cell count decreased,3,16183717
21,22.1,Malaise,6,16183717
22,22.1,Thrombocytopenia,1,16183717
23,22.1,Temperature intolerance,3,16183717
24,22.1,Insomnia,1,16183717
25,22.1,White blood cell count decreased,6,16183717
0,22.0,Neutrophil count decreased,1,16183718
0,22.1,Asthenia,6,16183726
1,22.1,Vomiting,6,16183726
2,22.1,Dizziness,6,16183726
3,22.1,Blood glucose increased,6,16183726
4,22.1,Insomnia,3,16183726
5,22.1,Arthralgia,3,16183726
6,22.1,Seizure,6,16183726
7,22.1,Hypertension,3,16183726
8,22.1,Memory impairment,6,16183726
9,22.1,Heart rate irregular,6,16183726
10,22.1,Urinary tract infection,3,16183726
11,22.1,Heart rate increased,6,16183726
12,22.1,Renal disorder,6,16183726
13,22.1,Contusion,6,16183726
0,22.0,Intestinal obstruction,6,16183727
1,22.0,Eating disorder,6,16183727
2,22.0,Arrhythmia,6,16183727
3,22.0,Fatigue,6,16183727
4,22.0,Feeling abnormal,6,16183727
5,22.0,Emotional disorder,6,16183727
6,22.0,Death,5,16183727
7,22.0,Atrial fibrillation,6,16183727
8,22.0,Blood creatinine increased,6,16183727
9,22.0,Nasopharyngitis,6,16183727
10,22.0,Cardiac arrest,6,16183727
11,22.0,Nausea,3,16183727
12,22.0,Sluggishness,3,16183727
13,22.0,Renal disorder,6,16183727
14,22.0,Blood potassium decreased,3,16183727
15,22.0,Atrial flutter,6,16183727
16,22.0,Platelet count decreased,6,16183727
17,22.0,Vomiting,6,16183727
0,22.1,Somnolence,6,16183728
1,22.1,Ear infection,6,16183728
2,22.1,Emotional disorder,6,16183728
3,22.1,Oropharyngeal pain,6,16183728
4,22.1,Diarrhoea,6,16183728
5,22.1,Product dose omission,6,16183728
6,22.1,Neuropathy peripheral,6,16183728
7,22.1,Musculoskeletal pain,6,16183728
8,22.1,Ligament sprain,3,16183728
9,22.1,Ear pain,6,16183728
10,22.1,Erythema,6,16183728
11,22.1,Arthralgia,3,16183728
12,22.1,Myalgia,6,16183728
13,22.1,Weight decreased,6,16183728
14,22.1,Headache,6,16183728
15,22.1,Intentional product misuse,6,16183728
16,22.1,Bone pain,6,16183728
17,22.1,Nausea,3,16183728
18,22.1,Platelet count decreased,1,16183728
19,22.1,Decreased appetite,3,16183728
20,22.1,Nasopharyngitis,6,16183728
21,22.1,Blood glucose increased,6,16183728
22,22.1,Feeling abnormal,6,16183728
23,22.1,Hyperhidrosis,6,16183728
24,22.1,Sinusitis,6,16183728
25,22.1,Blood iron decreased,6,16183728
26,22.1,Insomnia,3,16183728
27,22.1,Dehydration,3,16183728
28,22.1,Pruritus,6,16183728
29,22.1,Blood sodium decreased,6,16183728
0,22.0,Metastases to central nervous system,3,16183729
1,22.0,Vomiting,6,16183729
2,22.0,Disease progression,3,16183729
3,22.0,Metastatic neoplasm,6,16183729
4,22.0,Impaired gastric emptying,1,16183729
5,22.0,Nausea,6,16183729
6,22.0,Therapeutic product effect decreased,6,16183729
0,22.1,Dyspnoea exertional,3,16183730
1,22.1,Blood potassium decreased,6,16183730
2,22.1,Gout,6,16183730
3,22.1,Dizziness,1,16183730
4,22.1,Skin exfoliation,6,16183730
5,22.1,Nausea,3,16183730
6,22.1,Vomiting,1,16183730
7,22.1,Fatigue,3,16183730
8,22.1,Cough,3,16183730
9,22.1,Product dose omission,6,16183730
0,22.0,Dental fistula,3,16183787
1,22.0,Osteonecrosis of jaw,3,16183787
2,22.0,Cellulitis,3,16183787
0,22.0,Leukopenia,1,16183845
1,22.0,Thrombocytopenia,1,16183845
2,22.0,Pancytopenia,1,16183845
3,22.0,Neutropenia,1,16183845
4,22.0,Acute kidney injury,1,16183845
0,22.0,Generalised erythema,,16183864
1,22.0,Malaise,,16183864
2,22.0,Infusion related reaction,,16183864
3,22.0,Pruritus generalised,,16183864
0,22.0,Laryngospasm,1,16183904
1,22.0,Tachycardia,1,16183904
0,22.0,Death,,16183915
0,22.0,Death,5,16183954
0,22.0,Death,,16183976
0,22.0,Basal cell carcinoma,6,16183982
1,22.0,Neoplasm recurrence,6,16183982
0,22.0,Diarrhoea,,16183986
0,22.0,Vomiting,,16183990
1,22.0,Disease progression,,16183990
2,22.0,Nausea,,16183990
0,22.0,Disease progression,,16183994
0,22.1,Syncope,2,16184017
1,22.1,Gastrointestinal haemorrhage,1,16184017
2,22.1,Cholelithiasis,1,16184017
3,22.1,Small intestinal obstruction,5,16184017
4,22.1,Ischaemic stroke,3,16184017
5,22.1,Diarrhoea,3,16184017
0,22.0,Bone pain,6,16184034
0,22.0,Renal failure,,16184105
1,22.0,Dehydration,,16184105
0,22.0,Disease progression,,16184175
0,22.0,Malignant neoplasm progression,6,16184179
0,22.0,Glomerular filtration rate decreased,6,16184243
1,22.0,Heart rate increased,6,16184243
2,22.0,Snoring,6,16184243
3,22.0,Blood urea increased,6,16184243
4,22.0,Venous oxygen saturation decreased,6,16184243
5,22.0,Lipase abnormal,6,16184243
6,22.0,Blood creatinine increased,6,16184243
7,22.0,Blood pH abnormal,6,16184243
8,22.0,Depressed level of consciousness,6,16184243
9,22.0,Hypotension,6,16184243
10,22.0,Lipase increased,6,16184243
11,22.0,Respiratory rate decreased,6,16184243
12,22.0,Troponin increased,6,16184243
13,22.0,Overdose,6,16184243
0,22.0,Pain,6,16184258
0,22.0,Death,5,16184259
0,22.0,Syncope,1,16184314
1,22.0,Loss of consciousness,1,16184314
2,22.0,Emotional distress,1,16184314
0,22.0,Acute kidney injury,,16184335
1,22.0,Dialysis,,16184335
2,22.0,Mental status changes,,16184335
3,22.0,Metabolic acidosis,,16184335
0,22.0,Product physical issue,6,16184337
1,22.0,Pruritus,6,16184337
0,22.0,Disease progression,,16184400
0,22.0,Death,,16184406
0,22.0,Anaemia,3,16184465
1,22.0,Inappropriate antidiuretic hormone secretion,6,16184465
2,22.0,Hyponatraemia,2,16184465
3,22.0,Blood iron decreased,6,16184465
0,22.0,Renal impairment,1,16184469
1,22.0,Diarrhoea,1,16184469
2,22.0,Chest pain,1,16184469
3,22.0,Anaemia,1,16184469
4,22.0,Fatigue,3,16184469
5,22.0,Infection,1,16184469
6,22.0,Hypotension,1,16184469
7,22.0,Influenza,1,16184469
8,22.0,Bone marrow failure,6,16184469
9,22.0,Asthenia,3,16184469
10,22.0,Vomiting,1,16184469
11,22.0,Cough,3,16184469
12,22.0,Constipation,1,16184469
13,22.0,Dizziness,1,16184469
14,22.0,Dyspnoea,3,16184469
15,22.0,Neoplasm progression,6,16184469
0,22.0,Deep vein thrombosis,2,16184493
0,22.0,Death,,16184530
0,22.0,Bronchitis,6,16184545
0,22.0,Disease progression,,16184559
0,22.0,Extravasation,2,16184565
1,22.0,Tachycardia,2,16184565
0,22.0,Urine output decreased,6,16184620
1,22.0,Gait inability,6,16184620
2,22.0,Effusion,6,16184620
0,22.0,Paraesthesia,6,16184649
1,22.0,Gait disturbance,6,16184649
2,22.0,Hypoaesthesia,6,16184649
3,22.0,Pain in extremity,6,16184649
0,22.0,Dyspnoea,,16184758
0,22.1,Hypoacusis,6,16184762
1,22.1,Product dose omission,6,16184762
2,22.1,Pneumonia,6,16184762
0,22.0,Hot flush,1,16184768
1,22.0,Somnolence,1,16184768
2,22.0,Oxygen saturation decreased,1,16184768
3,22.0,Dysphagia,1,16184768
4,22.0,Dyspnoea,1,16184768
5,22.0,Nausea,1,16184768
0,22.0,Palpitations,1,16184799
0,22.0,Neutrophilia,1,16184854
1,22.0,Thrombocytopenia,1,16184854
2,22.0,Anaemia,1,16184854
0,22.0,Atrioventricular block,6,16184874
0,22.0,Lung disorder,1,16184902
0,22.0,Musculoskeletal stiffness,3,16184903
1,22.0,Asthenia,3,16184903
2,22.0,Hypertension,3,16184903
3,22.0,Arthralgia,3,16184903
4,22.0,Myalgia,3,16184903
0,22.0,Breast cancer,6,16184942
1,22.0,Malignant neoplasm progression,6,16184942
2,22.0,Metastases to bone,6,16184942
3,22.0,Metastases to liver,6,16184942
0,22.0,Alopecia,1,16184959
1,22.0,Madarosis,1,16184959
2,22.0,Alopecia,3,16184959
3,22.0,Hair disorder,3,16184959
4,22.0,Hair colour changes,3,16184959
5,22.0,Hair texture abnormal,3,16184959
0,22.1,Amnesia,1,16184964
1,22.1,Product dose omission,6,16184964
0,22.0,Stomatitis,1,16184978
1,22.0,Product use in unapproved indication,6,16184978
2,22.0,Neoplasm progression,6,16184978
3,22.0,Off label use,6,16184978
4,22.0,Rash maculo-papular,1,16184978
5,22.0,Bone pain,1,16184978
0,22.1,Pain in jaw,3,16184988
1,22.1,Diarrhoea,3,16184988
2,22.1,Asthenia,3,16184988
0,22.0,Cardiac failure,3,16185034
1,22.0,Atrial fibrillation,2,16185034
0,22.0,Tumour lysis syndrome,5,16185045
0,22.0,Pancreatic carcinoma metastatic,6,16185047
0,22.0,Face oedema,1,16185065
1,22.0,Vomiting,1,16185065
2,22.0,Abdominal pain upper,1,16185065
3,22.0,Tongue oedema,1,16185065
4,22.0,Oxygen saturation decreased,1,16185065
5,22.0,Hypotension,1,16185065
6,22.0,Hyperhidrosis,1,16185065
0,22.0,Delirium,6,16185075
1,22.0,Orthostatic hypotension,6,16185075
0,22.0,Bladder disorder,6,16185109
1,22.0,Nasopharyngitis,2,16185109
2,22.0,Full blood count decreased,6,16185109
0,22.0,Insomnia,2,16185136
1,22.0,Suicidal ideation,2,16185136
2,22.0,Major depression,2,16185136
0,22.0,Visual impairment,6,16185146
1,22.0,Malaise,6,16185146
2,22.0,Dizziness,6,16185146
3,22.0,Dyspnoea exertional,6,16185146
0,22.0,Diarrhoea,2,16185284
1,22.0,Pulmonary embolism,3,16185284
2,22.0,Vomiting,1,16185284
3,22.0,Speech disorder,1,16185284
4,22.0,Hypertension,1,16185284
5,22.0,Dysphonia,1,16185284
0,22.1,Extremity necrosis,2,16185367
1,22.1,Skin ulcer,2,16185367
0,22.0,Hair texture abnormal,3,16185423
1,22.0,Hair colour changes,3,16185423
2,22.0,Alopecia,3,16185423
3,22.0,Hair disorder,3,16185423
4,22.0,Madarosis,3,16185423
0,22.0,Hair disorder,3,16185425
1,22.0,Hair texture abnormal,3,16185425
2,22.0,Hair colour changes,3,16185425
3,22.0,Alopecia,3,16185425
4,22.0,Madarosis,3,16185425
0,22.0,Alopecia,3,16185426
1,22.0,Hair disorder,3,16185426
2,22.0,Hair texture abnormal,3,16185426
3,22.0,Hair colour changes,3,16185426
4,22.0,Madarosis,3,16185426
0,22.0,Hair colour changes,3,16185427
1,22.0,Hair disorder,3,16185427
2,22.0,Alopecia,3,16185427
3,22.0,Hair texture abnormal,3,16185427
0,22.0,Madarosis,3,16185428
1,22.0,Hair colour changes,3,16185428
2,22.0,Hair texture abnormal,3,16185428
3,22.0,Hair disorder,3,16185428
4,22.0,Alopecia,3,16185428
0,22.0,Vertigo,6,16185432
1,22.0,Alopecia,3,16185432
0,22.0,Diarrhoea,6,16185439
1,22.0,Dehydration,6,16185439
2,22.0,Renal failure,6,16185439
3,22.0,Hypotension,6,16185439
0,22.1,Pruritus,6,16185441
1,22.1,Asthenia,6,16185441
2,22.1,Cerebrovascular accident,6,16185441
0,22.0,Hair texture abnormal,3,16185463
1,22.0,Madarosis,3,16185463
2,22.0,Hair disorder,3,16185463
3,22.0,Hair colour changes,3,16185463
4,22.0,Alopecia,3,16185463
0,22.0,Death,5,16185557
0,22.0,Acute myeloid leukaemia,3,16185562
0,22.0,Torsade de pointes,3,16185563
1,22.0,Cardiac arrest,1,16185563
0,22.0,Metastasis,6,16185607
1,22.0,Fatigue,6,16185607
2,22.0,Product use in unapproved indication,6,16185607
3,22.0,Thyroid disorder,6,16185607
4,22.0,Condition aggravated,6,16185607
5,22.0,Abdominal pain upper,6,16185607
0,22.0,Product availability issue,6,16185740
1,22.0,Catheter site pain,6,16185740
2,22.0,Product dose omission,6,16185740
0,22.0,Neutropenia,6,16185835
1,22.0,Anaemia,6,16185835
0,22.1,Rash,6,16185980
1,22.1,Psychotic disorder,6,16185980
2,22.1,Intentional product use issue,6,16185980
0,22.0,Pain,3,16186020
1,22.0,Endoscopy,1,16186020
0,22.0,Inflammation,3,16186027
1,22.0,Administration site extravasation,3,16186027
2,22.0,Pain,3,16186027
0,22.0,Ejection fraction decreased,3,16186029
1,22.0,Cardiac failure,3,16186029
0,22.0,Fatigue,3,16186079
1,22.0,Constipation,3,16186079
2,22.0,Nausea,3,16186079
3,22.0,Somnolence,6,16186079
4,22.0,Diarrhoea,3,16186079
5,22.0,Emergency care,6,16186079
6,22.0,Breast disorder,6,16186079
7,22.0,Abdominal pain upper,6,16186079
8,22.0,Abdominal discomfort,6,16186079
9,22.0,Depression,6,16186079
0,22.0,Diarrhoea,2,16186089
1,22.0,Oropharyngeal pain,1,16186089
2,22.0,Cough,1,16186089
3,22.0,Abdominal pain upper,2,16186089
4,22.0,Nasopharyngitis,2,16186089
5,22.0,Emergency care,6,16186089
6,22.0,Fatigue,2,16186089
7,22.0,Nasal congestion,1,16186089
8,22.0,Product dose omission,6,16186089
0,22.0,Nausea,1,16186102
1,22.0,Pancreatic mass,6,16186102
2,22.0,Vomiting,1,16186102
3,22.0,Hospice care,6,16186102
0,22.0,Surgery,6,16186104
0,22.0,Death,5,16186109
0,22.0,Death,5,16186111
0,22.0,Pneumonia,6,16186112
0,22.0,Death,5,16186113
0,22.0,Inappropriate schedule of product administration,6,16186149
1,22.0,Syncope,1,16186149
2,22.0,Hypoglycaemia,1,16186149
0,22.0,Thyroid cancer,5,16186199
0,22.0,Acute kidney injury,3,16186231
0,22.0,Proteinuria,2,16186233
1,22.0,Haematuria,2,16186233
2,22.0,Hepatotoxicity,2,16186233
0,22.0,Hypersensitivity,1,16186237
1,22.0,Respiratory tract inflammation,1,16186237
2,22.0,Treatment noncompliance,6,16186237
3,22.0,Asphyxia,1,16186237
4,22.0,Angioedema,6,16186237
0,22.0,Disseminated intravascular coagulation,1,16186242
1,22.0,Haemolytic anaemia,1,16186242
2,22.0,Cerebral haemorrhage,2,16186242
3,22.0,White blood cell count decreased,1,16186242
0,22.0,Cardiorenal syndrome,2,16186274
1,22.0,Cor pulmonale acute,2,16186274
2,22.0,Pulmonary embolism,2,16186274
0,22.0,Drug intolerance,1,16186306
1,22.0,Off label use,6,16186306
0,22.0,Shock,1,16186341
1,22.0,Lactic acidosis,1,16186341
2,22.0,Dehydration,1,16186341
3,22.0,Coma,1,16186341
4,22.0,Hyperkalaemia,1,16186341
5,22.0,Acute kidney injury,2,16186341
6,22.0,Diarrhoea,1,16186341
7,22.0,Vomiting,1,16186341
0,22.0,Tumour lysis syndrome,4,16186365
0,22.0,Death,5,16186374
0,22.1,Asthenia,3,16186388
1,22.1,Blood albumin decreased,6,16186388
2,22.1,Death,5,16186388
3,22.1,Blood creatinine increased,6,16186388
4,22.1,Gamma-glutamyltransferase increased,6,16186388
5,22.1,Urinary retention,1,16186388
6,22.1,Diarrhoea,1,16186388
7,22.1,Alanine aminotransferase increased,6,16186388
0,22.0,Purpura,1,16186412
1,22.0,Blister,2,16186412
2,22.0,Wound necrosis,2,16186412
0,22.0,Asthenia,3,16186416
1,22.0,Paraesthesia,3,16186416
2,22.0,Alopecia,3,16186416
0,22.0,Peripheral coldness,2,16186453
1,22.0,Hypertension,,16186453
2,22.0,Fatigue,3,16186453
3,22.0,Appetite disorder,,16186453
4,22.0,Asthenia,3,16186453
5,22.0,Decreased appetite,2,16186453
6,22.0,Vomiting,,16186453
7,22.0,Dysphonia,,16186453
8,22.0,Blood potassium decreased,,16186453
9,22.0,Visual impairment,,16186453
10,22.0,Nausea,,16186453
11,22.0,Dehydration,,16186453
12,22.0,Stomatitis,3,16186453
13,22.0,Pain in extremity,,16186453
14,22.0,Product dose omission,,16186453
15,22.0,Neuropathy peripheral,3,16186453
16,22.0,Neuropathy peripheral,2,16186453
17,22.0,Diarrhoea,,16186453
18,22.0,Palmar erythema,3,16186453
0,22.0,Death,5,16186454
0,22.0,Pulmonary embolism,3,16186461
0,22.0,Metastases to bone,6,16186464
1,22.0,Metastases to liver,6,16186464
0,22.0,Hypersensitivity,1,16186470
1,22.0,Erythema,1,16186470
2,22.0,Abdominal pain,1,16186470
0,22.0,Colon cancer,5,16186499
0,22.0,Death,5,16186516
0,22.0,Cardiac failure,1,16186535
1,22.0,Malaise,1,16186535
2,22.0,Respiratory failure,1,16186535
0,22.0,Tracheostomy malfunction,6,16186540
1,22.0,Colitis,6,16186540
2,22.0,Diarrhoea,3,16186540
3,22.0,Medical device site irritation,6,16186540
4,22.0,Renal impairment,6,16186540
5,22.0,Nausea,3,16186540
6,22.0,Blood calcium decreased,6,16186540
0,22.0,Metastases to liver,6,16186552
0,22.0,Gastrointestinal disorder,1,16186585
1,22.0,Nausea,1,16186585
2,22.0,Pyrexia,1,16186585
3,22.0,Computerised tomogram thorax abnormal,1,16186585
4,22.0,Fatigue,1,16186585
5,22.0,Atelectasis,1,16186585
6,22.0,Hypoxia,1,16186585
7,22.0,Rash,1,16186585
8,22.0,Cough,1,16186585
9,22.0,Dyspnoea,1,16186585
0,22.0,Metastases to bone,6,16186668
1,22.0,Malignant neoplasm progression,6,16186668
0,22.0,Immunosuppression,6,16186671
1,22.0,HER-2 positive gastric cancer,6,16186671
2,22.0,Off label use,1,16186671
3,22.0,Malignant neoplasm progression,6,16186671
0,22.0,Dyspnoea,4,16186729
1,22.0,General physical health deterioration,4,16186729
0,22.0,Infection,5,16186754
0,22.0,Neutrophil count decreased,1,16186757
1,22.0,Drug hypersensitivity,1,16186757
2,22.0,Diarrhoea,1,16186757
0,22.0,Dehydration,2,16186758
1,22.0,Blood potassium increased,2,16186758
2,22.0,Diarrhoea,2,16186758
3,22.0,Blood creatinine increased,2,16186758
0,22.0,Anaemia,1,16186759
1,22.0,Interstitial lung disease,2,16186759
0,22.0,Anaemia,1,16186760
0,22.1,Cough,1,16186765
1,22.1,Pyrexia,1,16186765
2,22.1,Off label use,1,16186765
3,22.1,Dyspnoea,1,16186765
4,22.1,Hypoxia,1,16186765
5,22.1,Gastrointestinal disorder,1,16186765
6,22.1,Atelectasis,1,16186765
7,22.1,Nausea,1,16186765
8,22.1,Rash,1,16186765
9,22.1,Fatigue,1,16186765
0,22.0,Breast cancer metastatic,6,16186787
1,22.0,Malignant neoplasm progression,6,16186787
2,22.0,Cytopenia,6,16186787
3,22.0,Neutropenia,6,16186787
4,22.0,Pneumonitis,1,16186787
0,22.0,Product use in unapproved indication,6,16186791
1,22.0,Cough,6,16186791
0,22.0,Arthralgia,6,16186836
1,22.0,Colitis microscopic,2,16186836
0,22.0,Seasonal allergy,1,16186841
1,22.0,Sinusitis,1,16186841
2,22.0,Diarrhoea,1,16186841
3,22.0,Gastroenteritis viral,1,16186841
4,22.0,Vomiting,1,16186841
5,22.0,Malaise,1,16186841
6,22.0,Influenza,1,16186841
0,22.0,Breast cancer metastatic,5,16186862
0,22.1,Stomatitis,6,16186956
1,22.1,Dyspnoea,2,16186956
0,22.0,Pneumonia,3,16186960
1,22.0,Death,5,16186960
0,22.0,Cholangitis sclerosing,6,16186999
0,22.0,Stomatitis,6,16187060
0,22.0,Pulmonary haemorrhage,6,16187062
1,22.0,Pulmonary renal syndrome,6,16187062
0,22.0,Pneumonia,1,16187096
0,22.0,Pain,6,16187098
1,22.0,Blood uric acid increased,6,16187098
0,22.0,Product use in unapproved indication,6,16187126
1,22.0,Death,5,16187126
0,22.0,Oedema peripheral,2,16187137
1,22.0,Cardiac failure acute,2,16187137
0,22.0,Acute myeloid leukaemia,3,16187217
0,22.0,Cytopenia,6,16187341
1,22.0,Oedema,1,16187341
0,22.0,Neuropathy peripheral,3,16187348
0,22.0,Contusion,3,16187371
1,22.0,Joint swelling,3,16187371
2,22.0,Drug ineffective,1,16187371
0,22.0,Prescribed underdose,6,16187486
0,22.0,Radiation pneumonitis,1,16187499
1,22.0,Pneumonia,6,16187499
2,22.0,Malignant neoplasm progression,6,16187499
0,22.0,Proctalgia,1,16187527
0,22.0,Urticaria,1,16187529
1,22.0,Rash generalised,1,16187529
0,22.0,Hypersensitivity,1,16187545
1,22.0,Chills,1,16187545
2,22.0,Hyperventilation,1,16187545
3,22.0,Hyperthermia,1,16187545
4,22.0,Vomiting,1,16187545
0,22.0,Cardiac valve disease,6,16187608
1,22.0,Myocardial infarction,6,16187608
0,22.0,Eczema,3,16187615
1,22.0,Rash,3,16187615
2,22.0,Pruritus,3,16187615
3,22.0,Product use in unapproved indication,3,16187615
4,22.0,Rash erythematous,3,16187615
5,22.0,Skin exfoliation,3,16187615
0,22.0,Monoplegia,6,16187616
1,22.0,Hypopnoea,5,16187616
0,22.0,Product availability issue,6,16187625
1,22.0,Product dose omission,6,16187625
2,22.0,No adverse event,6,16187625
3,22.0,Intentional underdose,6,16187625
0,22.0,Renal failure,3,16187650
1,22.0,Metabolic acidosis,3,16187650
2,22.0,Product use in unapproved indication,6,16187650
0,22.0,Condition aggravated,6,16187706
1,22.0,Anaemia,1,16187706
2,22.0,Neutrophil count decreased,1,16187706
0,22.0,Malignant neoplasm progression,6,16187713
0,22.0,Aspartate aminotransferase increased,6,16187714
1,22.0,Glossodynia,6,16187714
2,22.0,Alanine aminotransferase increased,6,16187714
3,22.0,Myocarditis,6,16187714
4,22.0,Angina pectoris,6,16187714
5,22.0,Tongue disorder,6,16187714
6,22.0,Vomiting,3,16187714
0,22.0,Decreased appetite,1,16187716
1,22.0,Purulent discharge,6,16187716
2,22.0,Condition aggravated,6,16187716
3,22.0,Drug ineffective,6,16187716
0,22.0,Anaemia,1,16187722
1,22.0,Thrombocytopenia,6,16187722
2,22.0,Hepatic enzyme increased,1,16187722
0,22.0,Malignant neoplasm progression,6,16187723
0,22.0,Malignant neoplasm progression,6,16187735
1,22.0,Vomiting,6,16187735
2,22.0,Product storage error,6,16187735
3,22.0,Oedema,6,16187735
4,22.0,Product use in unapproved indication,6,16187735
5,22.0,Drug ineffective,6,16187735
6,22.0,Thyroid disorder,6,16187735
7,22.0,Off label use,6,16187735
0,22.0,Malignant neoplasm progression,6,16187757
0,22.0,Metastases to central nervous system,6,16187759
1,22.0,Alanine aminotransferase increased,6,16187759
0,22.0,Influenza,4,16187764
1,22.0,Pyrexia,4,16187764
2,22.0,Cough,4,16187764
0,22.0,Arthritis,6,16187765
0,22.0,Rash,2,16187784
1,22.0,Hepatic function abnormal,2,16187784
0,22.0,Breast cancer,5,16187814
1,22.0,Drug ineffective,6,16187814
0,22.0,Fall,1,16187815
1,22.0,Fracture,1,16187815
2,22.0,Anaemia,1,16187815
0,22.0,Fatigue,6,16187891
1,22.0,Malignant neoplasm progression,6,16187891
0,22.0,Pulmonary embolism,2,16188008
1,22.0,Cardiorenal syndrome,2,16188008
2,22.0,Cor pulmonale acute,2,16188008
0,22.0,Reversible cerebral vasoconstriction syndrome,1,16188009
0,22.0,Adverse drug reaction,6,16188080
0,22.0,Aphasia,3,16188082
1,22.0,Encephalopathy,3,16188082
0,22.0,Fatigue,6,16188093
1,22.0,Diarrhoea,6,16188093
2,22.0,Proteinuria,6,16188093
3,22.0,Bone marrow failure,6,16188093
4,22.0,Hypertension,6,16188093
5,22.0,Haemorrhage,6,16188093
6,22.0,Rash,6,16188093
7,22.0,Hepatic function abnormal,6,16188093
0,22.1,Death,5,16188133
1,22.1,Off label use,6,16188133
0,22.0,Small intestinal obstruction,1,16188160
1,22.0,Enteritis,1,16188160
0,22.0,Organising pneumonia,6,16188164
1,22.0,Pulmonary tuberculosis,6,16188164
0,22.0,Hepatic cancer recurrent,6,16188168
0,22.1,Speech disorder,6,16188202
1,22.1,Death,5,16188202
2,22.1,Gait inability,6,16188202
3,22.1,Blood glucose increased,6,16188202
0,22.0,Pain in extremity,6,16188204
1,22.0,Alopecia,6,16188204
2,22.0,Madarosis,6,16188204
0,22.0,General physical health deterioration,6,16188217
1,22.0,Asthenia,6,16188217
2,22.0,Intestinal obstruction,6,16188217
3,22.0,Impaired quality of life,6,16188217
4,22.0,Metastasis,6,16188217
5,22.0,Ascites,6,16188217
6,22.0,Suicidal ideation,6,16188217
7,22.0,Weight decreased,6,16188217
0,22.0,Pericardial effusion,6,16188237
1,22.0,Pleural effusion,6,16188237
2,22.0,Malignant neoplasm progression,6,16188237
0,22.1,Off label use,6,16188318
1,22.1,Deep vein thrombosis,6,16188318
2,22.1,Product use in unapproved indication,6,16188318
0,22.0,Metastases to peritoneum,6,16188339
1,22.0,Metastases to bone,6,16188339
2,22.0,Malignant neoplasm progression,6,16188339
3,22.0,Breast cancer metastatic,6,16188339
4,22.0,Metastases to liver,6,16188339
5,22.0,Metastases to skin,6,16188339
0,22.0,Bradycardia,2,16188397
1,22.0,Hypotension,2,16188397
0,22.0,Hepatitis cholestatic,2,16188399
0,22.0,Hepatitis cholestatic,3,16188408
0,22.0,Neutropenia,6,16188416
1,22.0,Large intestine perforation,1,16188416
2,22.0,Stomal hernia,1,16188416
3,22.0,Pneumoperitoneum,1,16188416
0,22.1,Hypotension,6,16188429
1,22.1,Syncope,1,16188429
2,22.1,Neutropenia,1,16188429
3,22.1,Pneumonia,1,16188429
4,22.1,Leukopenia,1,16188429
0,22.0,Sepsis,1,16188452
0,22.0,Neutropenia,2,16188464
0,22.0,Paraesthesia,3,16188476
1,22.0,Diarrhoea,3,16188476
0,22.1,Syncope,1,16188499
0,22.0,Loss of consciousness,5,16188500
1,22.0,Asthenia,3,16188500
2,22.0,Erythema,6,16188500
3,22.0,Platelet count decreased,6,16188500
4,22.0,Rash,6,16188500
5,22.0,Muscular weakness,6,16188500
6,22.0,Skin lesion,6,16188500
7,22.0,Metastases to central nervous system,6,16188500
8,22.0,Red blood cell count decreased,6,16188500
9,22.0,Oligodipsia,6,16188500
10,22.0,Cough,6,16188500
11,22.0,Dyspnoea,6,16188500
12,22.0,Petechiae,6,16188500
13,22.0,Decreased appetite,6,16188500
14,22.0,Ill-defined disorder,5,16188500
15,22.0,Metastases to lung,6,16188500
16,22.0,Rash pustular,2,16188500
17,22.0,Pain of skin,6,16188500
0,22.0,Myocardial ischaemia,1,16188524
1,22.0,Palpitations,6,16188524
2,22.0,Tremor,6,16188524
3,22.0,Back pain,6,16188524
4,22.0,Cardiac discomfort,6,16188524
5,22.0,Feeling abnormal,6,16188524
6,22.0,Tachycardia,1,16188524
7,22.0,Product packaging issue,6,16188524
0,22.0,Diffuse large B-cell lymphoma,1,16188538
1,22.0,Pancytopenia,2,16188538
0,22.1,Ileus,1,16188596
0,22.0,Fatigue,1,16188654
1,22.0,Diarrhoea,1,16188654
2,22.0,Intentional product misuse,6,16188654
0,22.0,Thrombosis,3,16188664
0,22.0,Large intestine perforation,6,16188671
1,22.0,Peritonitis,6,16188671
0,22.0,Death,5,16188685
0,22.0,Adenocarcinoma,6,16188693
1,22.0,Hepatic cancer recurrent,6,16188693
2,22.0,Drug ineffective,6,16188693
0,22.0,Malignant neoplasm progression,6,16188722
1,22.0,Metastases to liver,6,16188722
2,22.0,Metastases to bone,6,16188722
3,22.0,Breast cancer,6,16188722
0,22.0,Transient ischaemic attack,2,16188733
1,22.0,Gait disturbance,2,16188733
0,22.1,Hypokalaemia,6,16188745
1,22.1,Hepatic function abnormal,2,16188745
2,22.1,Fulminant type 1 diabetes mellitus,3,16188745
0,22.0,Fall,6,16188765
0,22.0,Dehydration,1,16188805
1,22.0,Pyrexia,1,16188805
2,22.0,Diarrhoea,1,16188805
3,22.0,Abdominal pain,1,16188805
0,22.0,Cerebrovascular accident,2,16188817
